Next Article in Journal
A Small Peptide Increases Drug Delivery in Human Melanoma Cells
Next Article in Special Issue
Introducing Fiber-Assisted Colorimetric Measurements as a Quality Control Tool of Hot Melt Extruded Filaments
Previous Article in Journal
Development of New Drugs for Autoimmune Hemolytic Anemia
Previous Article in Special Issue
Compounded Nonsterile Preparations and FDA-Approved Commercially Available Liquid Products for Children: A North American Update
 
 
Article
Peer-Review Record

Enhancing Dissolution and Oral Bioavailability of Ursodeoxycholic Acid with a Spray-Dried pH-Modified Extended Release Formulation

Pharmaceutics 2022, 14(5), 1037; https://doi.org/10.3390/pharmaceutics14051037
by Jaehyeok Lee 1, Chul Haeng Lee 2, Jong-Geon Lee 1, So Yeon Jeon 2, Min-Koo Choi 2 and Im-Sook Song 1,*
Reviewer 1: Anonymous
Reviewer 2: Anonymous
Pharmaceutics 2022, 14(5), 1037; https://doi.org/10.3390/pharmaceutics14051037
Submission received: 22 March 2022 / Revised: 24 April 2022 / Accepted: 9 May 2022 / Published: 11 May 2022
(This article belongs to the Special Issue Feature Papers in Physical Pharmacy and Formulation)

Round 1

Reviewer 1 Report

Please see the attachment.

Comments for author File: Comments.pdf

Author Response

Thank you for the reviewer’s valuable comments. 

Our point by point responses to the reviewer’s comments were attached. 

Author Response File: Author Response.pdf

Reviewer 2 Report

The authors describe a thorough study of the formulation, in vitro characterization and pharmacokinetic evaluation a bile acid oral formulation. Although the study is interesting and deserves publication, several issues should be resolved first:

  1. Abstract:
  • suggest to remove statement "Thus, maintaining higher pH at the absorption site is important for increasing its oral bioavailability.", as it does not follow from the previous sentence.

2. Materials and methods

  • Permeability measurements - caco2-cells can be adversely affected by bile salts, due to the lack of protective mucous layer. Was the viability and integrity of the Caco2-cell layer assessed before and after the permeation experiments (e.g. TEER values, permeation of a non-permeating markers, etc.)?
  • Spray-drying - what was the atomizing gas used? What was its flow rate? What was the flow rate of the aspirating gas (100% is not clear enough)?
  • Dissolution - distilled water was used for the dissolution studies, instead of biorelevant media with closer composition to the real in vivo situation, where the bile salts and phospholipids present in the intestinal fluids will greatly affect the obtained results for UDCA. These experiments need to be performed and the validity of the current conclusions should be checked

3. Results

  • Dissolution data (e.g. Fig. 4 and 5): the dissolution profile of the reference crystalline UCDA, and, possible a reference marketed product should be displayed, in order to evaluate the performance of the new formulations.

 

Author Response

Thank you for the reviewer’s valuable comments.

Our point by point responses to the reviewer’s comments were attached.

Author Response File: Author Response.pdf

Round 2

Reviewer 2 Report

The authors have addressed my comments and the manuscript is suitable for publication.

Back to TopTop